tiprankstipranks
Trending News
More News >
LENZ Therapeutics (LENZ)
NASDAQ:LENZ
US Market
Advertisement

LENZ Therapeutics (LENZ) Income Statement

Compare
187 Followers

LENZ Therapeutics Income Statement

Last quarter (Q1 2025), LENZ Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, LENZ Therapeutics's net income was $-14.62M. See LENZ Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 15.00M$ 0.00$ 0.00
Gross Profit
$ -58.00K$ -2.41M$ 6.65M$ -734.00K$ -121.00K
Operating Expenses
$ 58.55M$ 70.70M$ 97.29M$ 59.71M$ 13.38M
Depreciation and Amortization
$ 58.00K$ 15.00K$ 8.35M$ 734.00K$ 121.00K
EBITDA
$ -49.71M$ -122.24M$ -97.29M$ -70.03M$ -68.21M
Operating Income
$ -58.61M$ -73.11M$ -105.64M$ -60.44M$ -13.50M
Other Income/Expenses
$ 8.84M$ -51.54M$ 4.59M$ -10.32M$ -54.87M
Pretax Income
$ -49.77M$ -124.65M$ -101.05M$ -70.76M$ -68.37M
Net Income
$ -49.77M$ -124.65M$ -101.05M$ -70.76M$ -68.37M
Per Share Metrics
Basic EPS
$ -2.34$ -15.30$ -12.89$ -8.54$ -8.24
Diluted EPS
$ -2.34$ -15.30$ -12.89$ -8.54$ -8.24
Weighted Average Shares Outstanding
21.28M 8.15M 7.84M 8.29M 8.30M
Weighted Average Shares Outstanding (Diluted)
21.28M 8.15M 7.84M 8.29M 8.30M
Currency in USD

LENZ Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis